Rheumatology

Back to articles

Gout: Allopurinol use linked to lower CV risk, improved survival

KEY POINT

Use of urate-lowering therapies such as allopurinol in patients with gout reduced the risk of cardiovascular (CV)-related death and all-cause mortality compared with patients with gout who were not using these therapies.